Temozolomide

Thông số

85622-93-1Số CAS

630-358-9Số EC

3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamideTên IUPAC

C6H6N6O2Công thức hóa học

194.15 g/molKhối lượng phân tử

temozolomide; 85622-93-1; Methazolastone; Temodar; Temodal; 3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide; Temozolamide; CCRG-81045; Sch 52365; Temozolomidum; Sch-52365; NSC 362856; NSC-362856; temozolomida; M&B 39831; M&B-39831; CCRIS 8996; 3,4-dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide; MB 39831; M & B 39831; 8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one; DTXSID5043714; BRN 5547136; M-39831; 3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-1,2,3,5-tetrazine-8-carboxamide; 3-Methyl-4-oxo-3,4-dihydroimidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide; YF1K15M17Y; 3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-as-tetrazine-8-carboxamide; Mk-7365; NSC362856; 3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide; 3-methyl-4-oxo-3H,4H-imidazo[4,3-d][1,2,3,5]tetrazine-8-carboxamide; DTXCID3023714; CHEBI:72564; temomedac; 8-CARBAMOYL-3-METHYLIMIDAZO[5,1-D]-1,2,3,5-TETRAZIN-4(3H)-ONE; Imidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-; Temcad; 3-methyl-4-oxoimidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide; TMZ Bioshuttle; 3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d]-as-tetrazine-8-carboxamide; 3-methyl-4-oxo-3H,4H-imidazo(4,3-d)(1,2,3,5)tetrazine-8-carboxamide; TMZA-HE; RefChem:389304; M and B 39831; CCRG81045; L01AX03; M&B39831; RP-46161; Imidazo(5,1-d)-1,2,3,5-tetrazine-8-carboxamide, 3, 4-dihydro-3-methyl-4-oxo-; 630-358-9; Temozolomidum [Latin]; Temozolodida [Spanish]; CCRG 81045; C6H6N6O2; MFCD00866492; Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-; CHEMBL810; MLS002701861; NCGC00167429-01; Temozolodida; TMZ; 3-Methyl-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amide; SMR000466338; Temodal (TN); Temodar (TN); CAS-85622-93-1; Temozolomide, VETRANAL(TM), analytical standard; SR-01000759347; UNII-YF1K15M17Y; Methazolastone;; Temodal;; Temozolomide [USAN:INN:BAN]; Temozolomide CRS; IMIDAZO(5,1-D)-1,2,3,5-TETRAZINE-8-CARBOXAMIDE, 3,4-DIHYDRO-3-METHYL-4-OXO-; TMZ(Temozolomide); Temozolomide (Standard); Temozolomide 100 microg/mL in Acetonitrile; TEMOZOLOMIDE [MI]; TEMOZOLOMIDE [INN]; TEMOZOLOMIDE [JAN]; Temodar (TN) (Schering); TEMOZOLOMIDE [USAN]; SCHEMBL3739; TEMOZOLOMIDE [VANDF]; TEMOZOLOMIDE [MART.]; MLS000759447; MLS001424028; BIDD:GT0204; TEMOZOLOMIDE [USP-RS]; TEMOZOLOMIDE [WHO-DD]; GTPL7301; orb1223848; orb1309506; TEMOZOLOMIDE [EMA EPAR]; Temozolomide - Bio-X trade mark; Temozolomide (JP18/USAN/INN); Temozolomide, >=98% (HPLC); GLXC-02560; HMS2051O12; HMS2090B08; HMS2232N13; HMS3264I14; HMS3269P05; HMS3372K13; HMS3393O12; HMS3413D06; HMS3654N05; HMS3677D06; HMS3713H16; HMS5079A21; Pharmakon1600-01502289; TEMOZOLOMIDE [ORANGE BOOK]; TEMOZOLOMIDE [EP MONOGRAPH]; 3-methyl-4-oxo-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide; ALBB-021358; TEMOZOLOMIDE [USP MONOGRAPH]; Tox21_112433; AC-758; BDBM50034562; DL-190; EBC-00562; HY-17364R; MSK159181; NSC759883; s1237; STK623541; 3-Methyl-4-oxo-3,4-dihydroimidazo-[5,1-d][1,2,3,5]tetrazine-8-carboxamide; 3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetraazine-8-carboxamide; 3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide.; AKOS005557098; Tox21_112433_1; CCG-100870; CS-0943; DB00853; FT28027; KS-1216; NC00120; NSC-759883; NCGC00167429-02; NCGC00167429-04; NCGC00167429-05; NCGC00167429-12; NCGC00167429-16; BP-25388; BT164447; HY-17364; NCI60_003316; SY013764; NS00004198; SW197500-4; D06067; EN300-122324; AB00639915-06; AB00639915-08; AB00639915-09; AB00639915_10; AB00639915_11; F079436; Q425088; SR-01000759347-4; SR-01000759347-5; BRD-K32107296-001-04-5; BRD-K32107296-001-14-4; BRD-K32107296-001-15-1; BRD-K32107296-001-16-9; Z1201620684; 3-methyl-4-oxoimidazo [5,1-d] [1,2,3,5] tetrazine-8-carboxamide; Temozolomide, United States Pharmacopeia (USP) Reference Standard; 3-METHYL-4-OXO-8-IMIDAZOLO[5,1-D][1,2,3,5]TETRAZINECARBOXAMIDE; 3-Methyl-8-aminocarbonyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one; Imidazo[5,2,3,5-tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-; {Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide,} 3, 4-dihydro-3-methyl-4-oxo-; 3,4-dihydro-3-methyl-4-oxo-imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide; 3,4-Dihydro-3-methyl-4-oxo-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide; 3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide; Temozolomide, Pharmaceutical Secondary Standard; Certified Reference Material; 3-Methyl-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amide (Temozolomide); 3-Methyl-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amide(Temozolomide)Tên gọi khác